Trial Profile
A phase II study of metronomic oral chemotherapy with cyclophosphamide plus capecitabine and vinorelbine in metastatic breast cancer patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Jan 2016
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary) ; Capecitabine; Cyclophosphamide
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 04 Dec 2012 New trial record